These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 7521426

  • 1. [Examination in clinical course of HCV in interferon treatment].
    Kumada H.
    Nihon Rinsho; 1994 Jul; 52(7):1832-5. PubMed ID: 7521426
    [Abstract] [Full Text] [Related]

  • 2. Retreatment of chronic hepatitis C with interferon.
    Toyoda H, Nakano S, Takeda I, Kumada T, Sugiyama K, Osada T, Kiriyama S, Suga T, Ohki H, Ito O.
    Am J Gastroenterol; 1994 Sep; 89(9):1453-7. PubMed ID: 7521572
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Serum levels of HCV-RNA determined by branched DNA (bDNA) probe assay in chronic hepatitis C: method and clinical significance on interferon (IFN) therapy].
    Osada T, Iwabuchi S, Takatori M, Murayama M, Iino S.
    Nihon Rinsho; 1994 Jul; 52(7):1747-53. PubMed ID: 7521414
    [Abstract] [Full Text] [Related]

  • 5. [Study for relapse cases of chronic hepatitis C treated with interferon (IFN) and approach to more successful re-treatment of IFN].
    Iwabuchi S, Yoshida H, Fukui S.
    Nihon Rinsho; 1994 Jul; 52(7):1810-6. PubMed ID: 7521423
    [Abstract] [Full Text] [Related]

  • 6. [Predicting factors for the response to interferon therapy against hepatitis C virus infection: HCV genotyping].
    Yoshioka K, Kakumu S.
    Rinsho Byori; 1994 Oct; 42(10):1010-4. PubMed ID: 7527870
    [Abstract] [Full Text] [Related]

  • 7. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
    Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V.
    Hepatology; 1995 Oct; 22(4 Pt 1):1050-6. PubMed ID: 7557850
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load.
    Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Kobayashi M, Suzuki F, Akuta N, Someya T, Kumada H.
    J Gastroenterol; 2003 Oct; 38(2):158-63. PubMed ID: 12640530
    [Abstract] [Full Text] [Related]

  • 10. Sustained remission and viraemia in chronic hepatitis C treated with recombinant alpha-interferon (rIFN-alpha).
    Bresci G, Gambardella L, Parisi G, Banti S, Scatena F, Bertoni M, Capria A.
    Int J Clin Pharmacol Res; 1995 Oct; 15(5-6):175-9. PubMed ID: 8835615
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.
    Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C.
    Hepatology; 1997 Mar; 25(3):750-3. PubMed ID: 9049230
    [Abstract] [Full Text] [Related]

  • 13. Treatment of chronic hepatitis C with interferon alpha: long-term follow-up and prognostic relevance of HCV genotypes.
    Hopf U, Berg T, König V, Küther S, Heuft HG, Lobeck H.
    J Hepatol; 1996 Mar; 24(2 Suppl):67-73. PubMed ID: 8836892
    [Abstract] [Full Text] [Related]

  • 14. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S, Suzuki F, Hosaka T, Akuta N, Someya T, Kobayashi M, Tsubota A, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kumada H.
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [Abstract] [Full Text] [Related]

  • 15. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
    Olaso V, Córdoba J, Berenguer M, Prieto M, Lainez B, Argüello L, Valverde J, Pascual S, Gobernado M, Berenguer J.
    Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
    [Abstract] [Full Text] [Related]

  • 16. [Clinical studies on the detection of hepatitis C virus genome in the serum and the liver].
    Hige S.
    Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1382-98. PubMed ID: 7535730
    [Abstract] [Full Text] [Related]

  • 17. [Long-term interferon (IFN), neominophagen C (SNMC) combination therapy of active liver cirrhosis type C].
    Iwabuchi S, Osada T, Takatori M, Yoshida H.
    Nihon Rinsho; 1994 Jul; 52(7):1880-8. PubMed ID: 7521434
    [Abstract] [Full Text] [Related]

  • 18. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C.
    Karino Y, Toyota J, Sugawara M, Higashino K, Sato T, Ohmura T, Suga T, Okuuchi Y, Matsushima T.
    Am J Gastroenterol; 1997 Jan; 92(1):61-5. PubMed ID: 8995939
    [Abstract] [Full Text] [Related]

  • 19. [Comparative evaluation of serum HCV RNA by Roche Monitor Assay. Versions 1.0 and 2.0; as a predictive marker of subsequent response to IFN therapy].
    Takenokuchi M, Yasuda C, Nakamachi Y, Mukai M, Yoon S, Kondoh S, Kumagai S.
    Rinsho Byori; 2002 Apr; 50(4):392-7. PubMed ID: 12014019
    [Abstract] [Full Text] [Related]

  • 20. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta.
    Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, Kondo M, Hayashi Y, Jomori T, Suzuki S.
    Hepatology; 1993 Dec; 18(6):1319-25. PubMed ID: 8244255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.